ORTSSPEZIFISCHE INTEGRATION

European patent · EP2864489 · Deleted

Register entry

Publication number
EP2864489
Application number
EP13729962
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 20, 2013
Published
Apr 29, 2015
Granted
Mar 29, 2017
Deleted
Jun 30, 2017
Reason
Annual fee unpaid
IPC classes
C12N 15/90 (2006.01)
C12N 5/10 (2006.01)
C12N 15/10 (2006.01)
Priority
US 201261663147 P 22.06.2012
EP 12185330 21.09.2012
PCT application
PCT/EP2013/062859 20.06.2013
PCT publication
WO2013/190032 27.12.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 24, 2018

    Deleted, fee unpaid

    Published in Swissreg on 24.01.2018

  2. Mar 29, 2017

    Granted

    Published in Swissreg on 29.03.2017

Parties

Holder

Lonza Biologics plc

Lonza Biologics Plc.

228-230 Bath Road, Slough SL1 4DX, GB

Pfizer Inc.

235 East 42nd Street, New York, NY 10017, US

Inventor

RANCE, James

Thame Oxfordshire OX9 3TJ, GB

YOUNG, Robert

London Greater London NW2 1SR, GB

AGOSTINO, Michael J.

Andover, MA 01810, US

MOFFAT, Mark

Saint Louis, MO 63109, US

ZHANG, Lin

Boxford, MA 01921, US

ZHANG, Baohong

Needham, MA 02492, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.